Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes

Cancer Causes and Control

Volumn 22, Issue 4, 2011, Pages 623-629

  Ma, Xiaomei ^a   Wang, Rong ^a   Galili, Naomi ^b   Mayne, Susan T ^a   Wang, Sa A ^c   Yu, Herbert ^a   Raza, Azra ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Myelodysplastic syndromes; Smoking; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RISK FACTORS; SEX CHARACTERISTICS; SMOKING; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 79955776400     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9735-6     Document Type: Article

References (22)

1. Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD (2007) Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 7:118-129 (Pubitemid 46164747)
2. Ma X, Does M, Raza A, Mayne ST (2007) Myelodysplastic syndromes: incidence and survival in the United States. Cancer 109:1536-1542 (Pubitemid 46595689)
3. Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088 (Pubitemid 27132124)
4. Bennett J (2002) The myelodysplastic syndromes: pathobiology and clinical management. In: Cheson B (ed) Basic and clinical oncology, vol 27. Marcel Dekker, New York
5. Wang R, Gross CP, Halene S, Ma X (2009) Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States. Cancer Causes Control 20:1369-1376
6. Pogoda JM, Preston-Martin S, Nichols PW, Ross RK (2002) Smoking and risk of acute myeloid leukemia: results from a Los Angeles County case-control study. Am J Epidemiol 155: 546-553 (Pubitemid 34208046)
7. Fernberg P, Odenbro A, Bellocco R et al (2007) Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden. Cancer Res 67:5983-5986 (Pubitemid 46985035)
8. Kasim K, Levallois P, Abdous B, Auger P, Johnson KC (2005) Lifestyle factors and the risk of adult leukemia in Canada. Cancer Causes Control 16:489-500 (Pubitemid 40933619)
9. Chelghoum Y, Danaila C, Belhabri A et al (2002) Influence of cigarette smoking on the presentation and course of acute myeloid leukemia. Ann Oncol 13:1621-1627 (Pubitemid 35331461)
10. Varadarajan R, Licht A, Hyland AJ, et al. (2009) Smoking adversely affects survival in acute myeloid leukemia patients. ASH Annu Meet Abstr 114:979
11. International Standing Committee on Human Cytogenetic Nomenclature, Mitelman F (1995) ISCN 1995: an international system for human cytogenetic nomenclature (1995): recommendations of the international standing committee on human cytogenetic nomenclature, Memphis, Tennessee, USA, 9-13 Oct 1994. Karger, Basel
12. Bennett JM, Catovsky D, Daniel MT et al (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199 (Pubitemid 12073508)
13. Harris NL, Jaffe ES, Diebold J et al (1999) The World Health Organization classification of neoplastic diseases of the hemato- poietic and lymphoid tissues. Report of the clinical advisory committee meeting, airlie house, Virginia, November, 1997. Ann Oncol 10:1419-1432 (Pubitemid 30017051)
14. Vardiman JW, Harris NL, Brunning RD (2002) The world health organization (WHO) classification of the myeloid neoplasms. Blood 100:2292-2302
15. Thorne SL, Malarcher A, Maurice E, Caraballo R (2009) Cigarette smoking among adults-United States, 2007. JAMA 301: 373-375
16. Bjork J, Albin M, Mauritzson N, Stromberg U, Johansson B, Hagmar L (2000) Smoking and myelodysplastic syndromes. Epidemiology 11:285-291 (Pubitemid 30228196)
17. Bjork J, Johansson B, Broberg K, Albin M (2009) Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study. Leuk Res 33:788-791
18. Mauritzson N, Johansson B, Rylander L et al (2001) The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex. Br J Haematol 113:347-356 (Pubitemid 32523137)
19. United States (2004) Public health service. Office of the surgeon general. National center for chronic disease prevention and health promotion (U.S.). The health consequences of smoking a report of the Surgeon General. [Atlanta, Ga.]: U.S. Public Health Service, National Center for Chronic Disease Prevention and Health Promotion
20. World health organization (2004) IARC. International agency for research on cancer (2002: Lyon). Tobacco smoke and involuntary smoking: views and expert opinions of an IARC working group on the evaluation of carcinogenic risks to humans, which met in Lyon, 11-18 June 2002. IARC, Lyon
21. Holt PG (1987) Immune and inflammatory function in cigarette smokers. Thorax 42:241-249 (Pubitemid 17058936)
22. Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2:372-377 (Pubitemid 37328760)